SMTL ID : 6ecz.1

Bioreductive 4-hydroxy-3-nitro-5-ureido-benzenesulfonamides selectively target the tumor-associated carbonic anhydrase isoforms IX and XII and show hypoxia-enhanced cytotoxicity against human cancer cell lines.

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.21 Å

Oligo State

monomer

Ligands

1 x ZN: ZINC ION(Non-covalent)

ZN.1: 4 residues within 4Å: Chain A: H.91, H.93, H.116 Ligands: J4D.2 3 PLIP interactions: 3 interactions with chain A Metal complexes: A:H.91, A:H.93, A:H.116

1 x J4D: N-[2-hydroxy-3-nitro-5-(nitrosulfonyl)phenyl]-N'-(pentafluorophenyl)urea(Non-covalent)

J4D.2: 15 residues within 4Å: Chain A: N.59, H.61, A.62, N.64, Q.89, H.91, H.93, E.103, H.116, F.127, L.194, T.195, T.196, P.198 Ligands: ZN.1 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:L.194 Hydrogen bonds: A:N.64, A:Q.89, A:T.195, A:T.195, A:T.196

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Nocentini, A. et al., 4-Hydroxy-3-nitro-5-ureido-benzenesulfonamides Selectively Target the Tumor-Associated Carbonic Anhydrase Isoforms IX and XII Showing Hypoxia-Enhanced Antiproliferative Profiles. J. Med. Chem. (2018)

Release Date

2018-11-28

Peptides

Carbonic anhydrase 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Carbonic anhydrase 2

Related Entries With Identical Sequence